ORIFARM A/S: Financial statements 2014
CVR: 26058708
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ORIFARM A/S (CVR 26058708) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 1,149,174,000 and a net result of DKK 4,431,000 compared with DKK 4,473,000 the year before. That is an increase of 6.6% compared with the year before. The profit margin was 0.4%. Equity in the 2014 report amounted to DKK 22,793,000. The solvency ratio was 10.4%.
- Revenue
- DKK 1,149,174,000
- Gross Profit
- DKK 46,753,000
- Profit/Loss
- DKK 4,431,000
- Equity
- DKK 22,793,000
- Total Assets
- DKK 218,875,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 1.1 mia. | 46.8 mio. | 4.4 mio. | 22.8 mio. | - |
| 2013 | 1.1 mia. | 42.2 mio. | 4.5 mio. | 18.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ORIFARM A/S has published its annual report for 2013. Revenue came to DKK 1,078,460,000, and the net result was DKK 4,473,000.
As of April 9, 2014, Birgitte Bøgh-Sørensen has joined the board of directors of ORIFARM A/S.
As of April 9, 2014, Erik Sandberg has joined the board of directors of ORIFARM A/S.
As of April 9, 2014, Anna Rehman Linder has joined the board of directors of ORIFARM A/S.
As of April 9, 2014, Hans Christian Eberhard Groth Teisen has left the board of directors of ORIFARM A/S.
As of April 9, 2014, Jens Peter Nielsen is registered as adm. dir. of ORIFARM A/S.
As of April 9, 2014, Erik Sandberg has stepped down as adm. dir. of ORIFARM A/S.
About ORIFARM A/S
ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.